Valiant Labs Q2 FY26 results: revenue more than doubles YoY, turns profitable

Revenue Growth 20pctPat Growth 25pctNegative Operating CashflowResults View source PDF Explain this filing

VALIANTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.0%Reaction day

₹82.95

prior close

₹80.45

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.9%-3.9% vs market

On the reaction day the stock moved 3.9 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

+1.5

15m

+1.6

30m

+1.3

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

-3.0+0.9-3.9

Next day

-4.2+0.8-5.0

-4.7+0.7-5.4

-2.7+1.3-4.1

-4.4+0.5-5.0

-6.9+0.4-7.3

-12.1-1.5-10.6

15d

-21.9-2.4-19.5

-19.2-4.4-14.8

-21.3-7.2-14.1

-24.7-5.0-19.7

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved audited Q2 and H1 FY26 results (ended Sep 30, 2025). Standalone revenue jumped to Rs 9,699.49 lakh in H1 vs Rs 4,036.33 lakh last year, more than doubling. Net profit was Rs 196.24 lakh vs a loss of Rs 698.56 lakh. Q2 standalone revenue rose to Rs 4,529.77 lakh vs Rs 2,147.90 lakh. Consolidated results also turned profitable with H1 net profit of Rs 202.10 lakh vs a loss of Rs 525.01 lakh.

Likely market impact

Strong revenue growth and turnaround from loss to profit — positive for shareholders.